Wnt5a can both activate and repress Wnt/Β-catenin signaling during mouse embryonic development

Developmental Biology

Volumn 369, Issue 1, 2012, Pages 101-114

  Van Amerongen, Renée ^a,b   Fuerer, Christophe ^a,c   Mizutani, Makiko ^a   Nusse, Roel ^a  

^a STANFORD UNIVERSITY   (United States)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c EPFL   (Switzerland)

Author keywords

Calvarial mesenchyme; Development; Hair follicles; Mouse model; Ror2; Wnt5a

Indexed keywords

BETA CATENIN; T CELL FACTOR PROTEIN; WNT PROTEIN; WNT5A PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DERMIS; DEVELOPMENTAL DISORDER; DEVELOPMENTAL STAGE; EMBRYO; EMBRYO DEVELOPMENT; GENE INDUCTION; GENE REPRESSION; HAIR FOLLICLE; IN VIVO STUDY; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKULL MALFORMATION; TRANSGENIC MOUSE; WNT SIGNALING PATHWAY;

MAMMALIA; MUS MUSCULUS;

EID: 84864352822     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2012.06.020     Document Type: Article

References (104)

1. Adamska M., Billi A.C., Cheek S., Meisler M.H. Genetic interaction between Wnt7a and Lrp6 during patterning of dorsal and posterior structures of the mouse limb. Dev. Dyn. 2005, 233:368-372.
2. Al-Shawi R., Ashton S.V., Underwood C., Simons J.P. Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development. Dev. Genes Evol. 2001, 211:161-171.
3. Allgeier S.H., Lin T.M., Vezina C.M., Moore R.W., Fritz W.A., Chiu S.Y., Zhang C., Peterson R.E. WNT5A selectively inhibits mouse ventral prostate development. Dev. Biol. 2008, 324:10-17.
4. Andersson E.R., Prakash N., Cajanek L., Minina E., Bryja V., Bryjova L., Yamaguchi T.P., Hall A.C., Wurst W., Arenas E. Wnt5a regulates ventral midbrain morphogenesis and the development of A9-A10 dopaminergic cells in vivo. PLoS One 2008, 3:e3517.
5. Andl T., Reddy S.T., Gaddapara T., Millar S.E. WNT signals are required for the initiation of hair follicle development. Dev. Cell 2002, 2:643-653.
6. Baxley, S.E., Jiang, W., Serra, R., 2011. Misexpression of wingless-related MMTV integration site 5A in mouse mammary gland inhibits the milk ejection response and regulates connexin43 phosphorylation. Biol Reprod.
7. Carmon K.S., Loose D.S. Development of a bioassay for detection of Wnt-binding affinities for individual frizzled receptors. Anal. Biochem. 2010, 401:288-294.
8. Cervantes S., Yamaguchi T.P., Hebrok M. Wnt5a is essential for intestinal elongation in mice. Dev. Biol. 2009, 326:285-294.
9. Cha K.B., Douglas K.R., Potok M.A., Liang H., Jones S.N., Camper S.A. WNT5A signaling affects pituitary gland shape. Mech. Dev. 2004, 121:183-194.
10. Cha S.W., Tadjuidje E., Tao Q., Wylie C., Heasman J. Wnt5a and Wnt11 interact in a maternal Dkk1-regulated fashion to activate both canonical and non-canonical signaling in Xenopus axis formation. Development 2008, 135:3719-3729.
11. Chu E.Y., Hens J., Andl T., Kairo A., Yamaguchi T.P., Brisken C., Glick A., Wysolmerski J.J., Millar S.E. Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis. Development 2004, 131:4819-4829.
12. Croce J.C., McClay D.R. Evolution of the Wnt pathways. Methods Mol. Biol. 2008, 469:3-18.
13. Cui Y., Niziolek P.J., Macdonald B.T., Zylstra C.R., Alenina N., Robinson D.R., Zhong Z., Matthes S., Jacobsen C.M., Conlon R.A., Brommage R., Liu Q., Mseeh F., Powell D.R., Yang Q.M., Zambrowicz B., Gerrits H., Gossen J.A., He X., Bader M., Williams B.O., Warman M.L., Robling A.G. Lrp5 functions in bone to regulate bone mass. Nat. Med. 2011, 17:684-691.
14. DasGupta R., Fuchs E. Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development 1999, 126:4557-4568.
15. DeChiara T.M., Kimble R.B., Poueymirou W.T., Rojas J., Masiakowski P., Valenzuela D.M., Yancopoulos G.D. Ror2, encoding a receptor-like tyrosine kinase, is required for cartilage and growth plate development. Nat. Genet. 2000, 24:271-274.
16. Du S.J., Purcell S.M., Christian J.L., McGrew L.L., Moon R.T. Identification of distinct classes and functional domains of Wnts through expression of wild-type and chimeric proteins in Xenopus embryos. Mol. Cell. Biol. 1995, 15:2625-2634.
17. Duverger O., Morasso M.I. Epidermal patterning and induction of different hair types during mouse embryonic development. Birth Defects Res. C Embryo Today 2009, 87:263-272.
18. Fischer T., Guimera J., Wurst W., Prakash N. Distinct but redundant expression of the Frizzled Wnt receptor genes at signaling centers of the developing mouse brain. Neuroscience 2007, 147:693-711.
19. Gao B., Song H., Bishop K., Elliot G., Garrett L., English M.A., Andre P., Robinson J., Sood R., Minami Y., Economides A.N., Yang Y. Wnt signaling gradients establish planar cell polarity by inducing Vangl2 phosphorylation through Ror2. Dev. Cell 2011, 20:163-176.
20. Gerhart J. 1998 Warkany lecture: signaling pathways in development. Teratology 1999, 60:226-239.
21. Glinka A., Wu W., Delius H., Monaghan A.P., Blumenstock C., Niehrs C. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 1998, 391:357-362.
22. Gong Y., Slee R.B., Fukai N., Rawadi G., Roman-Roman S., Reginato A.M., Wang H., Cundy T., Glorieux F.H., Lev D., Zacharin M., Oexle K., Marcelino J., Suwairi W., Heeger S., Sabatakos G., Apte S., Adkins W.N., Allgrove J., Arslan-Kirchner M., Batch J.A., Beighton P., Black G.C., Boles R.G., Boon L.M., Borrone C., Brunner H.G., Carle G.F., Dallapiccola B., De Paepe A., Floege B., Halfhide M.L., Hall B., Hennekam R.C., Hirose T., Jans A., Juppner H., Kim C.A., Keppler-Noreuil K., Kohlschuetter A., LaCombe D., Lambert M., Lemyre E., Letteboer T., Peltonen L., Ramesar R.S., Romanengo M., Somer H., Steichen-Gersdorf E., Steinmann B., Sullivan B., Superti-Furga A., Swoboda W., van den Boogaard M.J., Van Hul W., Vikkula M., Votruba M., Zabel B., Garcia T., Baron R., Olsen B.R., Warman M.L. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001, 107:513-523.
23. Green J.L., Inoue T., Sternberg P.W. The C. elegans ROR receptor tyrosine kinase, CAM-1, non-autonomously inhibits the Wnt pathway. Development 2007, 134:4053-4062.
24. Grumolato L., Liu G., Mong P., Mudbhary R., Biswas R., Arroyave R., Vijayakumar S., Economides A.N., Aaronson S.A. Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev. 2010, 24:2517-2530.
25. He F., Xiong W., Yu X., Espinoza-Lewis R., Liu C., Gu S., Nishita M., Suzuki K., Yamada G., Minami Y., Chen Y. Wnt5a regulates directional cell migration and cell proliferation via Ror2-mediated noncanonical pathway in mammalian palate development. Development 2008, 135:3871-3879.
26. He X., Saint-Jeannet J.P., Wang Y., Nathans J., Dawid I., Varmus H. A member of the Frizzled protein family mediating axis induction by Wnt-5A. Science 1997, 275:1652-1654.
27. Ho H.Y., Susman M.W., Bikoff J.B., Ryu Y.K., Jonas A.M., Hu L., Kuruvilla R., Greenberg M.E. Wnt5a-Ror-Dishevelled signaling constitutes a core developmental pathway that controls tissue morphogenesis. Proc. Natl. Acad. Sci. USA 2012, 109:4044-4051.
28. Hochedlinger K., Yamada Y., Beard C., Jaenisch R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 2005, 121:465-477.
29. Hogan B. Manipulating the Mouse Embryo a Laboratory Manual 1994, Cold Spring Harbor Press, Plaqinview, NY. 2nd ed.
30. Hsieh J.C., Rattner A., Smallwood P.M., Nathans J. Biochemical characterization of Wnt-frizzled interactions using a soluble, biologically active vertebrate Wnt protein. Proc. Natl. Acad. Sci. USA 1999, 96:3546-3551.
31. Hu B., Lefort K., Qiu W., Nguyen B.C., Rajaram R.D., Castillo E., He F., Chen Y., Angel P., Brisken C., Dotto G.P. Control of hair follicle cell fate by underlying mesenchyme through a CSL-Wnt5a-FoxN1 regulatory axis. Genes Dev. 2010, 24:1519-1532.
32. Huelsken J., Vogel R., Erdmann B., Cotsarelis G., Birchmeier W. beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 2001, 105:533-545.
33. Ito Y., Yeo J.Y., Chytil A., Han J., Bringas P., Nakajima A., Shuler C.F., Moses H.L., Chai Y. Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects. Development 2003, 130:5269-5280.
34. Jacobs J.J., Kieboom K., Marino S., DePinho R.A., van Lohuizen M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 1999, 397:164-168.
35. James R.G., Conrad W.H., Moon R.T. Beta-catenin-independent Wnt pathways: signals, core proteins, and effectors. Methods Mol. Biol. 2008, 468:131-144.
36. Jiang X., Iseki S., Maxson R.E., Sucov H.M., Morriss-Kay G.M. Tissue origins and interactions in the mammalian skull vault. Dev Biol 2002, 241:106-116.
37. Kim G.H., Her J.H., Han J.K. Ryk cooperates with Frizzled 7 to promote Wnt11-mediated endocytosis and is essential for Xenopus laevis convergent extension movements. J. Cell. Biol. 2008, 182:1073-1082.
38. Kim H.J., Schleiffarth J.R., Jessurun J., Sumanas S., Petryk A., Lin S., Ekker S.C. Wnt5 signaling in vertebrate pancreas development. BMC Biol. 2005, 3:23.
39. Klaus A., Birchmeier W. Wnt signalling and its impact on development and cancer. Nat. Rev. Cancer 2008, 8:387-398.
40. Komiya Y., Habas R. Wnt signal transduction pathways. Organogenesis 2008, 4:68-75.
41. Kurayoshi M., Oue N., Yamamoto H., Kishida M., Inoue A., Asahara T., Yasui W., Kikuchi A. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res. 2006, 66:10439-10448.
42. Kusserow A., Pang K., Sturm C., Hrouda M., Lentfer J., Schmidt H.A., Technau U., von Haeseler A., Hobmayer B., Martindale M.Q., Holstein T.W. Unexpected complexity of the Wnt gene family in a sea anemone. Nature 2005, 433:156-160.
43. Kwee M.L., Balemans W., Cleiren E., Gille J.J., Van Der Blij F., Sepers J.M., Van Hul W. An autosomal dominant high bone mass phenotype in association with craniosynostosis in an extended family is caused by an LRP5 missense mutation. J. Bone Miner. Res. 2005, 20:1254-1260.
44. Leucht P., Minear S., Ten Berge D., Nusse R., Helms J.A. Translating insights from development into regenerative medicine: the function of Wnts in bone biology. Semin. Cell Dev. Biol. 2008, 19:434-443.
45. Levi B., Nelson E.R., Li S., James A.W., Hyun J.S., Montoro D.T., Lee M., Glotzbach J.P., Commons G.W., Longaker M.T. Dura mater stimulates human adipose-derived stromal to undergo bone formation in mouse calvarial defects. Stem Cells 2011.
46. Li C., Xiao J., Hormi K., Borok Z., Minoo P. Wnt5a participates in distal lung morphogenesis. Dev. Biol. 2002, 248:68-81.
47. Li J., Ying J., Fan Y., Wu L., Ying Y., Chan A.T., Srivastava G., Tao Q. WNT5A antagonizes WNT/beta-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma. Cancer Biol. Ther. 2010, 10:617-624.
48. Li S., Quarto N., Longaker M.T. Dura mater-derived FGF-2 mediates mitogenic signaling in calvarial osteoblasts. Am. J. Physiol. Cell Physiol. 2007, 293:C1834-1842.
49. Little R.D., Carulli J.P., Del Mastro R.G., Dupuis J., Osborne M., Folz C., Manning S.P., Swain P.M., Zhao S.C., Eustace B., Lappe M.M., Spitzer L., Zweier S., Braunschweiger K., Benchekroun Y., Hu X., Adair R., Chee L., FitzGerald M.G, Tulig C., Caruso A., Tzellas N., Bawa A., Franklin B., McGuire S., Nogues X., Gong G., Allen K.M., Anisowicz A., Morales A.J., Lomedico P.T., Recker S.M., Van Eerdewegh P., Recker R.R., Johnson M.L. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am. J. Hum. Genet. 2002, 70:11-19.
50. Lustig B., Jerchow B., Sachs M., Weiler S., Pietsch T., Karsten U., van de Wetering M., Clevers H., Schlag P.M., Birchmeier W., Behrens J. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol. Cell. Biol. 2002, 22:1184-1193.
51. MacDonald B.T., Tamai K., He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 2009, 17:9-26.
52. Maeda K., Kobayashi Y., Udagawa N., Uehara S., Ishihara A., Mizoguchi T., Kikuchi Y., Takada I., Kato S., Kani S., Nishita M., Marumo K., Martin T.J., Minami Y., Takahashi N. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. Nat. Med. 2012, 18:405-412.
53. Matsuda T., Nomi M., Ikeya M., Kani S., Oishi I., Terashima T., Takada S., Minami Y. Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development. Mech. Dev. 2001, 105:153-156.
54. McDonald S.L., Silver A. The opposing roles of Wnt-5a in cancer. Br. J. Cancer 2009, 101:209-214.
55. McLeod M.J. Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology 1980, 22:299-301.
56. Mii Y., Taira M. Secreted Frizzled-related proteins enhance the diffusion of Wnt ligands and expand their signalling range. Development 2009, 136:4083-4088.
57. Mikels A., Minami Y., Nusse R. Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling. J. Biol. Chem. 2009, 284:30167-30176.
58. Mikels A.J., Nusse R. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol. 2006, 4:e115.
59. Minear S., Leucht P., Jiang J., Liu B., Zeng A., Fuerer C., Nusse R., Helms J.A. Wnt proteins promote bone regeneration. Sci. Transl. Med. 2010, 2:29ra30.
60. Morvan F., Boulukos K., Clement-Lacroix P., Roman Roman S., Suc-Royer I., Vayssiere B., Ammann P., Martin P., Pinho S., Pognonec P., Mollat P., Niehrs C., Baron R., Rawadi G. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J. Bone Miner. Res. 2006, 21:934-945.
61. Nagy A., Gertsenstein M., Vintersten K., Behringer R. Staining mouse embryos for alkaline phosphatase activity. CSH Protoc 2007, pdb prot4776 2007.
62. Narhi K., Jarvinen E., Birchmeier W., Taketo M.M., Mikkola M.L., Thesleff I. Sustained epithelial beta-catenin activity induces precocious hair development but disrupts hair follicle down-growth and hair shaft formation. Development 2008, 135:1019-1028.
63. Nemeth M.J., Topol L., Anderson S.M., Yang Y., Bodine D.M. Wnt5a inhibits canonical Wnt signaling in hematopoietic stem cells and enhances repopulation. Proc. Natl. Acad. Sci. USA 2007, 104:15436-15441.
64. Nguyen H., Merrill B.J., Polak L., Nikolova M., Rendl M., Shaver T.M., Pasolli H.A., Fuchs E. Tcf3 and Tcf4 are essential for long-term homeostasis of skin epithelia. Nat. Genet. 2009, 41:1068-1075.
65. Nishita M., Itsukushima S., Nomachi A., Endo M., Wang Z., Inaba D., Qiao S., Takada S., Kikuchi A., Minami Y. Ror2/Frizzled complex mediates Wnt5a-induced AP-1 activation by regulating Dishevelled polymerization. Mol. Cell. Biol. 2010, 30:3610-3619.
66. Nomachi A., Nishita M., Inaba D., Enomoto M., Hamasaki M., Minami Y. Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A. J. Biol. Chem. 2008, 283:27973-27981.
67. O'Connell M.P., Fiori J.L., Xu M., Carter A.D., Frank B.P., Camilli T.C., French A.D., Dissanayake S.K., Indig F.E., Bernier M., Taub D.D., Hewitt S.M., Weeraratna A.T. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. Oncogene 2010, 29:34-44.
68. Oishi I., Suzuki H., Onishi N., Takada R., Kani S., Ohkawara B., Koshida I., Suzuki K., Yamada G., Schwabe G.C., Mundlos S., Shibuya H., Takada S., Minami Y. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells 2003, 8:645-654.
69. Olson D.J., Gibo D.M. Antisense wnt-5a mimics wnt-1-mediated C57MG mammary epithelial cell transformation. Exp. Cell Res. 1998, 241:134-141.
70. Peng C., Zhang X., Yu H., Wu D., Zheng J. Wnt5a as a predictor in poor clinical outcome of patients and a mediator in chemoresistance of ovarian cancer. Int. J. Gynecol. Cancer 2011, 21:280-288.
71. Pinson K.I., Brennan J., Monkley S., Avery B.J., Skarnes W.C. An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 2000, 407:535-538.
72. Plikus M.V., Baker R.E., Chen C.C., Fare C., de la Cruz D., Andl T., Maini P.K., Millar S.E., Widelitz R., Chuong C.M. Self-organizing and stochastic behaviors during the regeneration of hair stem cells. Science 2011, 332:586-589.
73. Qian D., Jones C., Rzadzinska A., Mark S., Zhang X., Steel K.P., Dai X., Chen P. Wnt5a functions in planar cell polarity regulation in mice. Dev. Biol. 2007, 306:121-133.
74. Quarto N., Behr B., Longaker M.T. Opposite spectrum of activity of canonical Wnt signaling in the osteogenic context of undifferentiated and differentiated mesenchymal cells: implications for tissue engineering. Tissue Eng. Part A 2010, 16:3185-3197.
75. Reddy S., Andl T., Bagasra A., Lu M.M., Epstein D.J., Morrisey E.E., Millar S.E. Characterization of Wnt gene expression in developing and postnatal hair follicles and identification of Wnt5a as a target of Sonic hedgehog in hair follicle morphogenesis. Mech. Dev. 2001, 107:69-82.
76. Roarty K., Baxley S.E., Crowley M.R., Frost A.R., Serra R. Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype. Breast Cancer Res. 2009, 11:R19.
77. Roman-Gomez J., Jimenez-Velasco A., Cordeu L., Vilas-Zornoza A., San Jose-Eneriz E., Garate L., Castillejo J.A., Martin V., Prosper F., Heiniger A., Torres A., Agirre X. WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia. Eur. J. Cancer 2007, 43:2736-2746.
78. Sato A., Yamamoto H., Sakane H., Koyama H., Kikuchi A. Wnt5a regulates distinct signalling pathways by binding to Frizzled2. Embo. J. 2010, 29:41-54.
79. Schlake T., Sick S. Canonical WNT signalling controls hair follicle spacing. Cell Adh. Migr. 2007, 1:149-151.
80. Shimizu H., Julius M.A., Giarre M., Zheng Z., Brown A.M., Kitajewski J. Transformation by Wnt family proteins correlates with regulation of beta-catenin. Cell Growth Differ. 1997, 8:1349-1358.
81. Sick S., Reinker S., Timmer J., Schlake T. WNT and DKK determine hair follicle spacing through a reaction-diffusion mechanism. Science 2006, 314:1447-1450.
82. Spector, J.A., Greenwald, J.A., Warren, S.M., Bouletreau, P.J., Crisera, F.E., Mehrara, B.J., Longaker, M.T., 2002. Co-culture of osteoblasts with immature dural cells causes an increased rate and degree of osteoblast differentiation. Plast. Reconstr. Surg. 109, 631-642; discussion 643-634..
83. Summerhurst K., Stark M., Sharpe J., Davidson D., Murphy P. 3D representation of Wnt and Frizzled gene expression patterns in the mouse embryo at embryonic day 11.5 (Ts19). Gene Expr. Patterns 2008, 8:331-348.
84. Tai C.C., Sala F.G., Ford H.R., Wang K.S., Li C., Minoo P., Grikscheit T.C., Bellusci S. Wnt5a knock-out mouse as a new model of anorectal malformation. J. Surg. Res. 2009, 156:278-282.
85. Takada R., Hijikata H., Kondoh H., Takada S. Analysis of combinatorial effects of Wnts and Frizzleds on beta-catenin/armadillo stabilization and Dishevelled phosphorylation. Genes Cells 2005, 10:919-928.
86. Takeuchi S., Takeda K., Oishi I., Nomi M., Ikeya M., Itoh K., Tamura S., Ueda T., Hatta T., Otani H., Terashima T., Takada S., Yamamura H., Akira S., Minami Y. Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formation. Genes Cells 2000, 5:71-78.
87. Tamai K., Semenov M., Kato Y., Spokony R., Liu C., Katsuyama Y., Hess F., Saint-Jeannet J.P., He X. LDL-receptor-related proteins in Wnt signal transduction. Nature 2000, 407:530-535.
88. Tao Q., Yokota C., Puck H., Kofron M., Birsoy B., Yan D., Asashima M., Wylie C.C., Lin X., Heasman J. Maternal wnt11 activates the canonical wnt signaling pathway required for axis formation in Xenopus embryos. Cell 2005, 120:857-871.
89. Topol L., Jiang X., Choi H., Garrett-Beal L., Carolan P.J., Yang Y. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J. Cell Biol. 2003, 162:899-908.
90. Torres M.A., Yang-Snyder J.A., Purcell S.M., DeMarais A.A., McGrew L.L., Moon R.T. Activities of the Wnt-1 class of secreted signaling factors are antagonized by the Wnt-5A class and by a dominant negative cadherin in early Xenopus development. J. Cell Biol. 1996, 133:1123-1137.
91. Vivatbutsiri P., Ichinose S., Hytonen M., Sainio K., Eto K., Iseki S. Impaired meningeal development in association with apical expansion of calvarial bone osteogenesis in the Foxc1 mutant. J. Anat. 2008, 212:603-611.
92. Wallingford J.B., Vogeli K.M., Harland R.M. Regulation of convergent extension in Xenopus by Wnt5a and Frizzled-8 is independent of the canonical Wnt pathway. Int. J. Dev. Biol. 2001, 45:225-227.
93. Wehrli M., Dougan S.T., Caldwell K., O'Keefe L., Schwartz S., Vaizel-Ohayon D., Schejter E., Tomlinson A., DiNardo S. arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 2000, 407:527-530.
94. Willert K., Brown J.D., Danenberg E., Duncan A.W., Weissman I.L., Reya T., Yates J.R., Nusse R. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 2003, 423:448-452.
95. Williams B.O., Insogna K.L. Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone. J. Bone Miner. Res. 2009, 24:171-178.
96. Witte F., Dokas J., Neuendorf F., Mundlos S., Stricker S. Comprehensive expression analysis of all Wnt genes and their major secreted antagonists during mouse limb development and cartilage differentiation. Gene Expr. Patterns 2009, 9:215-223.
97. Wong G.T., Gavin B.J., McMahon A.P. Differential transformation of mammary epithelial cells by Wnt genes. Mol. Cell. Biol. 1994, 14:6278-6286.
98. Wu C.H., Nusse R. Ligand receptor interactions in the Wnt signaling pathway in Drosophila. J. Biol. Chem. 2002, 277:41762-41769.
99. Yamada M., Udagawa J., Matsumoto A., Hashimoto R., Hatta T., Nishita M., Minami Y., Otani H. Ror2 is required for midgut elongation during mouse development. Dev. Dyn. 2010, 239:941-953.
100. Yamaguchi T.P., Bradley A., McMahon A.P., Jones S. A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development 1999, 126:1211-1223.
101. Yamamoto H., Oue N., Sato A., Hasegawa Y., Matsubara A., Yasui W., Kikuchi A. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene 2010, 29:2036-2046.
102. Yamamoto S., Nishimura O., Misaki K., Nishita M., Minami Y., Yonemura S., Tarui H., Sasaki H. Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex. Dev. Cell 2008, 15:23-36.
103. Yang Y., Topol L., Lee H., Wu J. Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation. Development 2003, 130:1003-1015.
104. Ying J., Li H., Chen Y.W., Srivastava G., Gao Z., Tao Q. WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor. Blood 2007, 110:4130-4132.